Elehear Beyond Pro vs Lexie B3

The Elehear Beyond Pro is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.2/5 in our lab testing, placing it #11 out of 65 OTC devices tested. At $631, this behind-the-ear rechargeable device delivers strong overall performance and has earned HearAdvisor's Expert's Choice Award for both 2024 and 2025. In our testing, the Beyond Pro excels in music streaming, scoring 3.8/5—a solid result that sits 1.88 points above the OTC category average of 1.92/5. Speech clarity in quiet environments also performs well at 3.3/5, which is 0.46 points above average. Speech in noise scores 2.5/5, which is above the category average by 1.00 points, though this remains a mixed result in absolute terms. Feedback handling is excellent at a perfect 5.0/5. The primary limitation is own-voice comfort, which scores 1.2/5—a low result that falls 1.31 points below the category average. Users sensitive to hearing their own voice may find this more noticeable. The device uses closed domes with a medium-power receiver and achieved identical scores in both initial and tuned fit conditions in our testing. The Beyond Pro supports both iPhone and Android streaming with hands-free functionality. It's best suited for users who prioritize streaming audio quality and speech clarity and are less sensitive to own-voice occlusion effects. Within its price range, it competes with devices like the Sony CRE-E10 and Lexie B2 Plus, though some competitors in this tier score higher overall.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.